Aegis acts Sole Bookrunner on $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals
New York, New York / GLOBE NEWSWIRE/ December 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on an $8 Million Underwritten...
Aegis acts Sole Bookrunner on $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals
Aegis acted as Exclusive Placement Agent on $3 Million Private Placement for Bruush Oral Care Inc.
Aegis acted as Sole Bookrunner on $8 Million Underwritten Public Offering for RedHill Biopharma Ltd.